EFFECT OF THE LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS(PERMIXON(R)) AND ITS MAJOR COMPONENTS ON BASIC FIBROBLAST GROWTH FACTOR-INDUCED PROLIFERATION OF CULTURES OF HUMAN PROSTATE BIOPSIES
M. Paubertbraquet et al., EFFECT OF THE LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS(PERMIXON(R)) AND ITS MAJOR COMPONENTS ON BASIC FIBROBLAST GROWTH FACTOR-INDUCED PROLIFERATION OF CULTURES OF HUMAN PROSTATE BIOPSIES, European urology, 33(3), 1998, pp. 340-347
Objective: To assess the effect of the lipidosterolic extract of Seren
oa repens (LSESr) on in vitro cell proliferation in biopsies of human
prostate Material and Methods: Cell proliferation was assessed by inco
rporation of [H-3]thymidine followed by historadiography. Results: Bas
ic fibroblast growth factor (b-FGF) induced a considerable increase in
human prostate cell proliferation (from +100 to +250%); the glandular
epithelium was mainly affected, minimal labeling being recorded in th
e other regions of the prostate. Similar results were observed with ep
idermal growth factor (EGF), although the increase in cell proliferati
on was not recorded in some cases. Lovastatin, an inhibitor of hydroxy
methylglutaryl coenzyme A, antagonized both the basal proliferation an
d the growth factor-stimulated proliferation of human prostate epithel
ium (EGF, mean inhibition approximate to 80-95%; b-FGF, mean inhibitio
n approximate to 40-90%). Geraniol, a precursor of both farnesyl pyrop
hosphate and geranylgeranyl pyrophosphate, and farnesol, the precursor
of farnesyl pyrophosphate, increased cell proliferation only in some
prostate specimens, this effect being antagonized by lovastatin. LSESr
did not affect basal prostate cell proliferation, with the exception
of two prostate specimens in which a significant inhibition of basal p
roliferation was observed with the highest concentration of LSESr (30
mu g/ml). In contrast, LSESr inhibited b-FGF-induced proliferation of
human prostate cell cultures; this effect was significant for the high
est concentration of LSESr (30 mu g/ml). In some prostate samples, a s
imilar inhibition was also noted with lower concentrations. Unsaturate
d fatty acids (UFA), in the range 1-30 ng/ml, did not affect the basal
prostate cell proliferation, only a slight increase in cell prolifera
tion was noted in 1 prostate specimen. UFA(1, 10 or 30 mu g/ml) marked
ly inhibited the b-FGF-induced cell proliferation down to the basal va
lue. Lupenone, hexacosanol and the unsaponified fraction of LSESr mark
edly inhibited the b-FGF-induced cell proliferation, whereas a minimal
effect on basal cell proliferation was noted. Conclusions: Despite th
e large variability in the response of the prostate samples to b-FGF,
these results indicate that LSESr and its components affect the prolif
erative response of prostate cells to b-FGF more than their basal prol
iferation.